Pretransplant mixed lymphocyte culture still has an impact on graft survival

American Journal of Nephrology

Volumn 24, Issue 3, 2004, Pages 296-300

  El Agroudy, Amgad E ^a   Ismail, Amani M ^a   El Chenawy, Farha A ^a   Shehab El Din, Ahmed B ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Mixed lymphocyte culture; Transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ACUTE GRAFT REJECTION; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOREACTIVITY; KIDNEY DISEASE; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; ORGAN DONOR; PRIORITY JOURNAL; SAMPLE SIZE; SEX RATIO;

ADULT; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 4043109844     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078224     Document Type: Article

References (12)

1. Harmon WE, Parkman R, Lavin PT, Grup WE, Ingelfinger JR, Yunis EJ, Levey RH: Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol 1982;129:1573-1577.
2. Nishigaki F, Nozaki M, Nakamura A, Tantguchi M, Kobayashi K, Hirano T: Significance of histocompatibility tests. Rinsho Byori 1990;38:151-156.
3. Kerman RH, Katz SM, Schenberg L, Baraket O, Van Buren O, Kahan BD: Ten-year followup of mixed lymphocyte reaction hyperresponsive living related cyclosporine monotherapy treated renal allograft recipients. Transplant Proc 1997;29:198.
4. Agrawal S, Singh AK, Sharma RK, Gupta A, Kumar A, Kapoor R, Bhandari M: In vitro pretransplant mixed lymphocyte culture response and acute rejection episodes. Transplant Proc 1998;30:2974.
5. Karman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD: Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 1991;51:338-342.
6. Lazda VA, Jonasson O, Mozes MF: Relationship of mixed lymphocyte culture (MLC) response and Kidney graft survival in Living related donor transplants. Transplant Proc 1981;13:949-952.
7. Holman DM, Dunn TB, Ward M, Raofi V, Jovanovic B, Kumins NH, Lazda AV, Pollak R, Benedetti E: Pretransplant MLC in the presence of cyclosporine may predict renal allograft survival. Transplant Proc 1999;31:746-747.
8. Lshido N, Matsouka J, Tandka S, Matsuno T, Tanaka N: Donor specific hyporesponsiveness in a clinically tolerant renal transplant recipients. Transplant Proc 1999;31:2880-2882.
9. Flechner SM, Kerman RH, Van Buren CT, Epps L, Kahan BD: The use of cyclosporine in living-related renal transplantation: Donorspecific hyporesponsiveness and steroid withdrawal. Transplantation 1984;38:685-691.
10. Francis DMA, Dumble LJ, Bowes L, Clunie GJ, MacDonald JM: Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation 1988;46:853-856.
11. Reinsmoen NL, Matas AJ: Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1983;55:1017-1023.
12. Massy ZA, Guijarro C, Wiederkehr MR: Chronic renal allograft rejection: Immunologic and non-immunologic risk factors. Kidney Int 1996;49:518-522.